Start a new topic and get direct answers from the Expert Advice Community.
CREATE NEW TOPIC +Guest
If I understand the question correctly, you are asking is ISO 13485:2016 quality management system documentation the same for disposable medical devices and IVD devices. Yes, basic documentation is the same, the only difference is the procedures and work instructions for the production process (what kind of the production it is, is it necessary to produce them in the cleanroom or not, is there a sterilization process involved and similar).
For more details which documents are mandatory for ISO 13485:2016, please see the following links:
On the following link, you can see how our ISO 13485:2016 documentation toolkit looks like - https://advisera.com/13485academy/iso-13485-documentation-toolkit/
I invite you to watch this free webinar on demand about “How to perform an ISO 14001:2015 internal audit” - https://advisera.com/14001academy/webinar/how-to-perform-an-iso-14001-2015-internal-audit-free-webinar-on-demand/ where this process
is presented and several tips are shared.
Please check this information below with more detailed answer:
ISO 27001 was designed to be implemented in organizations of any size and industry, and broadly speaking, these are the general steps to implement it on any organization:
Regarding ISO 27001 implementation approaches, you have three options:
Each one of them has its advantages and disadvantages, related to time, resources, and knowledge. For more information, I suggest the following materials:
Advisera is specialized in the third approach. We offer toolkits with templates and expert support, and also free material in the form of articles, papers, and webinars, to help you with your implementation project. Please see these materials for more information:
This article will provide you a further explanation about ISMS implementation:
These materials will also help you regarding ISO 27001 implementation:
I'm assuming that by the second reference you mean ISO 14001.
Considering that, with the increase in the attacks aiming private and corporate information, the increase in the dependence of information to provided services, and potential impacts due to realized risks, we see an increase in the adoption of ISO 27001 by organizations, but not to be the most important standard (since ISO 9001 is focused on customer satisfaction, it will remain the most popular ISO management system standard).
For IVD Medical Devices for Infectious Diseases e.g. Covid-19 are these classified in IVDR as high-risk Class D?
In which class is some IVD for COVID-19 depends on what type of the test it is. There are three main types of detection assays relevant for COVID-19 diagnostic testing and screening:
According to IVD Directive 98/79/EC Article 9, on conformity assessment procedures, for COVID-19 diagnostic devices that are not intended for use as self-tests, the manufacturer shall, in order to affix the CE marking, draw up the EC declaration of conformity required before placing the devices on the market. This is a self-declaration procedure based on satisfying essential safety and performance requirements listed in the Directive and specifications of the device performance characteristics, stated by the manufacturer. In case of self-tests, the involvement of a third-party conformity assessment body is necessary.
European Commission has published a document which proposes a tentative definition of COVID-19 diagnostic test performance criteria (analytical sensitivity, analytical specificity, clinical sensitivity, and clinical specificity) - Current performance of COVID-19 test methods and devices and proposed performance criteria - Working document of Commission services https://ec.europa.eu/docsroom/documents/40805
European Commission also published a searchable database. The objective of the JRC COVID-19 In Vitro Diagnostic Devices and Test Methods Database is to collect in a single place all publicly available information on the performance of CE-marked in vitro diagnostic medical devices (IVDs) as well as in-house laboratory-developed devices and related test methods for COVID-19. - COVID-19 In Vitro Diagnostic Devices and Test Methods Database https://covid-19-diagnostics.jrc.ec.europa.eu/
And must the CE Mark have the NB 4 digit Number next to the CE Mark?
This depends again on what kind of diagnostic test it is. If it is self-test than it needs NB 4 digit numbers, if it is not then there is a self-declaration and there is no need for the NB 4 digit numbers next tot he CE mark.
First is important to note that ISO 27001 does not prescribe how to document interested parties, so documenting them by name or by category are acceptable approaches.
But please note that, to fulfill clause 7.4 - Communication, you need to determine with whom to communicate, and depending on the information to be communicated, maybe it will be necessary to identify clients individually in certain circumstances.
This article will provide you a further explanation about interested parties:
These materials will also help you regarding interested parties:
I'm assuming you are referring only to controls from section A.17.1
Considering that, controls from ISO 27001 Annex A section A.17 (Information security aspects of business continuity management) aims to minimize risks that, in case of an event that disrupts business operations, the information will be kept protected, and operations that rely on them will be resumed as quickly as possible.
To show compliance with controls of this section an organization needs to:
This article will provide you a further explanation about business continuity for ISO 27001:
These materials will also help you regarding business continuity for ISO 27001:
1. How can ISO 27001 ensure data integrity in a company that needs to create all its security policies from scratch
ISO 27001 Annex A has controls that can be applied to minimize risks that information is changed or destroyed without authorization (e.g., A.9.1.1 Access control policy, and A.12.1.2 Change management), and that changes performed can be tracked and undone if needed (e.g., A.12.4.1 Event logging, and A.12.3.1 Information backup), thus helping protect information integrity.
For further information, see:
This material will also help you regarding ISO 27001 controls:
2. is the return on investment of an ISO 27001 project feasible?
ISO 27001 was designed to help organizations apply controls based on relevant requirements and in levels related to their risk tolerance.
Considering that, provided that the ISO 27001 project is aligned to the business' and interested parties' (e.g., customers, regulation bodies, suppliers, etc.) needs and objectives, its return on investment is feasible.
This article will provide you a further explanation about ISO 27001 implementation:
To develop a security culture you must consider these points:
For further information, see:
This material will also help you regarding awareness and training:
You are going to audit the Management Representative. An audit is about collecting evidence from the contrast between reality and audit criteria. You should start by collecting the audit criteria. Which documents, in your QMS, mention the Management Representative and its authorities and responsibilities? Then, read that documentation and look for situations that you think you want to check, that you want to confirm. For example, you may read that the Management Representative is responsible for conducting quarterly performance reviews about processes and action plans. You can ask to see evidence that the performance review took place, what its decisions were, and if it has a positive impact on the organizations’ performance. For example, you may read that the Management Representative is responsible for ensuring that corrective actions are implemented, effective, and closed. You can ask to see evidence that shows if corrective actions are defined, implemented, evaluated as effective, and closed.
You can find more information below: